文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

将柏林定义扩展至高流量鼻氧患者:COVID-19所致急性低氧性呼吸衰竭的观察性研究

Broadening the Berlin definition of ARDS to patients receiving high-flow nasal oxygen: an observational study in patients with acute hypoxemic respiratory failure due to COVID-19.
PubMed 文献 · Ann Intensive Care · 2023-07-14
一句话结论在COVID-19急性低氧性呼吸衰竭患者中,采用扩展的柏林定义可使接受高流量鼻氧的患者被诊断为ARDS,但高流量鼻氧组与机械通气组的基线特征和ICU死亡率不同(22.7% vs 35.6%,p=0.001)。

该多中心观察性研究纳入728例COVID-19所致急性低氧性呼吸衰竭的成年危重患者,将柏林定义中「需要至少5 cm H2O PEEP的机械通气」替换为「高流量鼻氧的最低气流速率要求」,所有患者均符合扩展的柏林定义。229例起始接受高流量鼻氧、499例起始接受机械通气,高流量鼻氧组疾病严重程度评分更低、PaO2/FiO2更低。高流量鼻氧组ICU死亡率低于机械通气组(22.7% vs 35.6%,p=0.001)。按PaO2/FiO2轻、中、重度分层,高流量鼻氧组ICU死亡率分别为16.7%、22.0%、23.5%(p=0.906),机械通气组分别为19.1%、37.9%、41.4%(p=0.002)。作者认为扩展定义可能有助于高流量鼻氧患者更早诊断ARDS,但两组基线特征与死亡率不同。

要点

  • 所有728例COVID-19急性低氧性呼吸衰竭患者均符合扩展的柏林定义(以高流量鼻氧最低气流速率替代5 cm H2O PEEP通气要求)。
  • 高流量鼻氧组229例ICU死亡率为22.7%,机械通气组499例为35.6%(p=0.001)。
  • 高流量鼻氧组疾病严重程度评分更低、PaO2/FiO2更低。
  • 按PaO2/FiO2轻度、中度、重度分层,高流量鼻氧组ICU死亡率16.7%、22.0%、23.5%(p=0.906),机械通气组19.1%、37.9%、41.4%(p=0.002)。
  • 作者认为扩展定义可能有助于高流量鼻氧患者更早诊断ARDS,但两组基线特征和死亡率不同。

适用人群与场景

  • 成年危重患者,急性低氧性呼吸衰竭由COVID-19所致,来自多中心观察性研究。
  • 纳入患者中229例起始接受高流量鼻氧,499例起始接受机械通气。

诊断标准与关键阈值

  • 扩展的柏林定义:将原定义中「需要至少5 cm H2O PEEP的机械通气」替换为「高流量鼻氧的最低气流速率要求」,符合该扩展定义即可诊断ARDS。
  • 采用原ARDS定义中使用的PaO2/FiO2界值将患者分为轻度、中度、重度动脉低氧血症组。

研究设计与关键结果

  • 多中心观察性研究,纳入728例COVID-19所致急性低氧性呼吸衰竭的成年危重患者,229例起始接受高流量鼻氧、499例起始接受机械通气,所有患者均符合扩展的柏林定义。
  • 主要终点ICU死亡率:高流量鼻氧组22.7% vs 机械通气组35.6%(p=0.001)。
  • 高流量鼻氧组疾病严重程度评分更低、PaO2/FiO2更低。
  • 按PaO2/FiO2轻度、中度、重度分层,高流量鼻氧组ICU死亡率分别为16.7%、22.0%、23.5%(p=0.906),机械通气组分别为19.1%、37.9%、41.4%(p=0.002)。
  • 次要终点包括医院死亡率、第28天和第90天死亡率、起始高流量鼻氧患者7天内需要机械通气的比例、无高流量鼻氧或机械通气天数、ICU和医院住院时长。

证据类型、等级与局限

  • 证据类型:多中心观察性研究。
  • 试验注册:ClinicalTrials.gov(标识号NCT04719182)。
  • 局限:原文未报告局限性

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: High-flow nasal oxygen (HFNO) is increasingly used in patients with acute hypoxemic respiratory failure. It is uncertain whether a broadened Berlin definition of acute respiratory distress syndrome (ARDS), in which ARDS can be diagnosed in patients who are not receiving ventilation, results in similar groups of patients receiving HFNO as in patients receiving ventilation.

METHODS: We applied a broadened definition of ARDS in a multicenter, observational study in adult critically ill patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19), wherein the requirement for a minimal level of 5 cm H2O PEEP with ventilation is replaced by a minimal level of airflow rate with HFNO, and compared baseline characteristics and outcomes between patients receiving HFNO and patients receiving ventilation. The primary endpoint was ICU mortality. We also compared outcomes in risk for death groups using the PaO2/FiO2 cutoffs as used successfully in the original definition of ARDS. Secondary endpoints were hospital mortality; mortality on days 28 and 90; need for ventilation within 7 days in patients that started with HFNO; the number of days free from HFNO or ventilation; and ICU and hospital length of stay.

RESULTS: Of 728 included patients, 229 patients started with HFNO and 499 patients with ventilation. All patients fulfilled the broadened Berlin definition of ARDS. Patients receiving HFNO had lower disease severity scores and lower PaO2/FiO2 than patients receiving ventilation. ICU mortality was lower in receiving HFNO (22.7 vs 35.6%; p = 0.001). Using PaO2/FiO2 cutoffs for mild, moderate and severe arterial hypoxemia created groups with an ICU mortality of 16.7%, 22.0%, and 23.5% (p = 0.906) versus 19.1%, 37.9% and 41.4% (p = 0.002), in patients receiving HFNO versus patients receiving ventilation, respectively.

CONCLUSIONS: Using a broadened definition of ARDS may facilitate an earlier diagnosis of ARDS in patients receiving HFNO; however, ARDS patients receiving HFNO and ARDS patients receiving ventilation have distinct baseline characteristics and mortality rates.

TRIAL REGISTRATION: The study is registered at ClinicalTrials.gov (identifier NCT04719182).

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. van der Ven FLIM, Valk CMA, Blok S, et al. Broadening the Berlin definition of ARDS to patients receiving high-flow nasal oxygen: an observational study in patients with acute hypoxemic respiratory failure due to COVID-19. Ann Intensive Care. 2023. PMID: 37452196. doi:10.1186/s13613-023-01161-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。